Feasibility and efficacy of adjuvant gemcitabine chemotherapy after liver transplantation for proximal bile duct cancer

Trial Profile

Feasibility and efficacy of adjuvant gemcitabine chemotherapy after liver transplantation for proximal bile duct cancer

Recruiting
Phase of Trial: Phase II

Latest Information Update: 31 Jan 2014

At a glance

  • Drugs Gemcitabine (Primary)
  • Indications Cholangiocarcinoma
  • Focus Therapeutic Use
  • Acronyms pro-duct 001
  • Most Recent Events

    • 13 Jul 2013 New source identified and integrated (European Clinical Trials Database record: EudraCT2010-020480-21).
    • 17 Apr 2013 Status changed from planning to recruiting as reported by German Clinical Trials Register.
    • 21 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top